Danone Acquires Huel: A Strategic Move Toward Functional Nutrition
Danone has officially announced its acquisition of Huel, a British shake and powder company known for competing with brands like Soylent and Joylent in the “complete nutrition” sector. The deal, valued at approximately €1 billion, sends shockwaves throughout the food industry, primarily due to its implications in the realm of functional nutrition.
The Rise of Functional Nutrition
The food landscape is rapidly shifting, notably influenced by the emergence of GLP-1 drugs, such as Ozempic, which are changing consumer eating habits. As a response, major companies are scrambling to secure their foothold in functional nutrition, primarily through acquisitions like Danone’s.
What is Huel?
Founded in 2015, Huel has quickly established itself as a formidable player in the meal replacement market. With a projected turnover of around £250 million in 2025 and sales in over 100 countries, Huel features well-known investors, including celebrities like Idris Elba and Jonathan Ross. Huel specializes in nutritionally complete meals, offering powders, shakes, bars, and instant meals, designed to cover 100% of daily nutritional needs. However, the company also advises supplementing its offerings with conventional food to create a balanced diet.
Danone’s Strategic Intentions
The question remains: why is Danone pursuing this acquisition? This decision aligns with its “Renew Danone” strategy, initiated in 2022, which aims to diversify and expand the company’s operations. Prior to this acquisition, Danone already possessed Nutricia, its specialized medical nutrition division that produces oncological supplements and pediatric formulas. Incorporating Huel allows Danone to construct a comprehensive ecosystem of functional nutrition, spanning from clinical applications to mass-market consumption.
A Thriving and Growing Market
The functional nutrition market, particularly meal replacements, is estimated to be worth between $16 billion and $21 billion annually, with predictions of continued growth exceeding 5% in the coming years. This expansion is driven by contemporary dietary trends, including a growing focus on nutritional density and healthier eating.
The Influence of GLP-1 Drugs
The impact of GLP-1 medications is significant. Users are increasingly opting for foods that offer maximal nutritional value while reducing intake of ultra-processed options. According to Circana, households with GLP-1 users are expected to account for 35% of food sales in the U.S. by 2030. Industry competitors, such as Nestlé and General Mills, are already adapting their product lines to cater to this new dietary paradigm.
The Timing of the Acquisition
Danone is capitalizing on its strong financial position, having registered a cash flow exceeding €3 billion in 2024. The company’s CEO has emphasized a desire to “go on the offensive with acquisitions,” making this purchase of Huel a timely move to solidify its role in the changing landscape of nutrition.
Conclusion: A New Era of Food
Ultimately, Danone’s acquisition of Huel signifies more than mere corporate growth; it marks a pivotal shift in how food is perceived and marketed. Instead of focusing solely on pleasure and convenience, the future of food is increasingly centered on functional benefits, driven by emerging consumer needs and technological advancements in nutrition.